Regulatory T Cells Ameliorate Intrauterine Growth Retardation in a Transgenic Rat Model for Preeclampsia

Preeclampsia is a multisystemic syndrome during pregnancy that is often associated with intrauterine growth retardation. Immunologic dysregulation, involving T cells, is implicated in the pathogenesis. The aim of this study was to evaluate the effect of upregulating regulatory T cells in an established transgenic rat model for preeclampsia. Application of superagonistic monoclonal antibody for CD28 has been shown to effectively upregulate regulatory T cells. In the first protocol (treatment protocol), we applied 1 mg of CD28 superagonist or control antibody on days 11 and 15 of pregnancy. In the second protocol (prevention protocol), the superagonist or control antibody was applied on days 1, 5, and 9. Superagonist increased regulatory T cells in circulation and placenta from 8.49±2.09% of CD4-positive T cells to 23.50±3.05% and from 3.85±1.45% to 23.27±7.64%, respectively. Blood pressure and albuminuria (30.6±15.1 versus 14.6±5.5 mg/d) were similar in the superagonist or control antibody–treated preeclamptic group for both protocols. Rats treated with CD28 superagonist showed increased pup weights in the prevention protocol (2.66±0.03 versus 2.37±0.05 g) and in the treatment protocol (3.04±0.04 versus 2.54±0.1 g). Intrauterine growth retardation, calculated by brain:liver weight ratio, was also decreased by the superagonist in both protocols. Further analysis of brain development revealed a 20% increase in brain volume by the superagonist. Induction of regulatory T cells in the circulation and the uteroplacental unit in an established preeclamptic rat model had no influence on maternal hypertension and proteinuria. However, it substantially improved fetal outcome by ameliorating intrauterine growth retardation.

[1]  A. Shennan,et al.  Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy. , 2015, Obstetrics and gynecology.

[2]  M. Cipolla,et al.  Magnesium Sulfate Treatment Reverses Seizure Susceptibility and Decreases Neuroinflammation in a Rat Model of Severe Preeclampsia , 2014, PloS one.

[3]  G. Hutchison,et al.  Imaging of activated complement using ultrasmall superparamagnetic iron oxide particles (USPIO) - conjugated vectors: an in vivo in utero non-invasive method to predict placental insufficiency and abnormal fetal brain development , 2014, Molecular Psychiatry.

[4]  S. Kang,et al.  Short chain fatty acids induce both effector and regulatory T cells by suppression of histone deacetylases and regulation of the mTOR-S6K pathway , 2014, Mucosal Immunology.

[5]  Fu-jun Liu,et al.  Adoptive transfer of pregnancy-induced CD4+CD25+ regulatory T cells reverses the increase in abortion rate caused by interleukin 17 in the CBA/JxBALB/c mouse model. , 2014, Human reproduction.

[6]  H. Einsele,et al.  Human regulatory T cells are selectively activated by low‐dose application of the CD28 superagonist TGN1412/TAB08 , 2014, European journal of immunology.

[7]  James M. Roberts,et al.  Hypertension in Pregnancy: Executive Summary , 2013 .

[8]  W. D. de Jonge,et al.  Dietary Inhibitors of Histone Deacetylases in Intestinal Immunity and Homeostasis , 2013, Front. Immunol..

[9]  W. David,et al.  Pre-eclampsia , 2012 .

[10]  G. Chaouat,et al.  Regulatory T cells and reproduction: how do they do it? , 2012, Journal of reproductive immunology.

[11]  M. Owens,et al.  Hypertension in response to CD4(+) T cells from reduced uterine perfusion pregnant rats is associated with activation of the endothelin-1 system. , 2012, American journal of physiology. Regulatory, integrative and comparative physiology.

[12]  J. Golden,et al.  Delayed Myelination in an Intrauterine Growth Retardation Model Is Mediated by Oxidative Stress Upregulating Bone Morphogenetic Protein 4 , 2012, Journal of neuropathology and experimental neurology.

[13]  G. Wallukat,et al.  Activating autoantibodies to the angiotensin II type I receptor play an important role in mediating hypertension in response to adoptive transfer of CD4+ T lymphocytes from placental ischemic rats. , 2012, American journal of physiology. Regulatory, integrative and comparative physiology.

[14]  M. Cipolla,et al.  Pregnant serum induces neuroinflammation and seizure activity via TNFα , 2012, Experimental Neurology.

[15]  Kazuhiko Yamamoto,et al.  Regulatory T Cell-Mediated Control of Autoantibody-Induced Inflammation , 2012, Front. Immun..

[16]  M. Zeier,et al.  Pregnancy‐associated diseases are characterized by the composition of the systemic regulatory T cell (Treg) pool with distinct subsets of Tregs , 2012, Clinical and experimental immunology.

[17]  Mary Tolcos,et al.  Intrauterine growth restriction affects the maturation of myelin , 2011, Experimental Neurology.

[18]  F. Claas,et al.  Fetus specific T cell modulation during fertilization, implantation and pregnancy. , 2011, Placenta.

[19]  Santosh A. Khedkar,et al.  Pilot Study of Extracorporeal Removal of Soluble Fms-Like Tyrosine Kinase 1 in Preeclampsia , 2011, Circulation.

[20]  G. Wallukat,et al.  Angiotensin II Type 1 Receptor Antibodies and Increased Angiotensin II Sensitivity in Pregnant Rats , 2011, Hypertension.

[21]  B. Huppertz,et al.  Effects of Circulating and Local Uteroplacental Angiotensin II in Rat Pregnancy , 2010, Hypertension.

[22]  F. Luft,et al.  Inhibition of Trophoblast-Induced Spiral Artery Remodeling Reduces Placental Perfusion in Rat Pregnancy , 2010, Hypertension.

[23]  K. Sugamura,et al.  Regulatory T cells are necessary for implantation and maintenance of early pregnancy but not late pregnancy in allogeneic mice. , 2010, Journal of reproductive immunology.

[24]  S. Saito.  Th17 cells and regulatory T cells: new light on pathophysiology of preeclampsia , 2010, Immunology and cell biology.

[25]  R. Dechend,et al.  Changes in endovascular trophoblast invasion and spiral artery remodelling at term in a transgenic preeclamptic rat model. , 2010, Placenta.

[26]  I. Sargent,et al.  REVIEW ARTICLE: Immunology of Pre‐Eclampsia , 2010, American journal of reproductive immunology.

[27]  R. Plehm,et al.  Regulatory T Cells Ameliorate Angiotensin II–Induced Cardiac Damage , 2009, Circulation.

[28]  Tiejuan Mi,et al.  Angiotensin receptor agonistic autoantibodies induce pre-eclampsia in pregnant mice , 2008, Nature Medicine.

[29]  G. Wallukat,et al.  Dysregulation of the Circulating and Tissue-Based Renin–Angiotensin System in Preeclampsia , 2007, Hypertension.

[30]  Nicki Panoskaltsis,et al.  Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412. , 2006, The New England journal of medicine.

[31]  H. Volk,et al.  Pre‐eclampsia is not Associated with Changes in the Levels of Regulatory T Cells in Peripheral Blood , 2005, American journal of reproductive immunology.

[32]  S. Saito,et al.  Toll-like receptor 4: a potential link between "danger signals," the innate immune system, and preeclampsia? , 2005, American journal of obstetrics and gynecology.

[33]  T. Hünig,et al.  CD28 superagonists: mode of action and therapeutic potential. , 2005, Immunology letters.

[34]  R. Gold,et al.  Selective targeting of regulatory T cells with CD28 superagonists allows effective therapy of experimental autoimmune encephalomyelitis , 2005, The Journal of experimental medicine.

[35]  G. Wallukat,et al.  Agonistic Autoantibodies to the AT1 Receptor in a Transgenic Rat Model of Preeclampsia , 2005, Hypertension.

[36]  H. Volk,et al.  Abnormal T-cell reactivity against paternal antigens in spontaneous abortion: adoptive transfer of pregnancy-induced CD4+CD25+ T regulatory cells prevents fetal rejection in a murine abortion model. , 2005, The American journal of pathology.

[37]  Y. Sasaki,et al.  Decidual and peripheral blood CD4+CD25+ regulatory T cells in early pregnancy subjects and spontaneous abortion cases. , 2004, Molecular human reproduction.

[38]  A. G. Betz,et al.  Regulatory T cells mediate maternal tolerance to the fetus , 2004, Nature Immunology.

[39]  G Koren,et al.  Fall in mean arterial pressure and fetal growth restriction in pregnancy hypertension: a meta-analysis , 2000, The Lancet.

[40]  G. Wallukat,et al.  Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor. , 1999, The Journal of clinical investigation.

[41]  T. Hanke,et al.  CD28‐mediated induction of proliferation in resting T cells in vitro and in vivo without engagement of the T cell receptor: Evidence for functionally distinct forms of CD28 , 1997, European journal of immunology.

[42]  A. Fukamizu,et al.  Hypertension Induced in Pregnant Mice by Placental Renin and Maternal Angiotensinogen , 1996, Science.

[43]  C. Martyn.  Fetal and infant origins of cardiovascular disease. , 1994, Midwifery.

[44]  J. Scott,et al.  IMMUNOLOGY OF PRE-ECLAMPSIA , 1978, The Lancet.